Clin Osteol 2021; 26(1): 40-44

Pseudohypoparathyroidism type Ib: a case report and review of literatureCase reports

Pseudohypoparathyroidism (PHP) is a group of rare hereditary diseases caused by tissue resistance to parathyroid hormone (PTH), there are two main types I and II. Type I is divided into subtypes. The authors present a case of PHP Ib with hypocalcemia accidentally detected at childbirth. After the unsuccessful treatment of hypocalc­emia, the etiology was considered. Although PHP was considered and treatment was tried, the confirmation of the diagnosis and the treatment were not adequately tightened. Years later, PHP Ib has been genetically confirmed. By adjusting the treatment, the difficulties subsided and the effect of PTH on bone was reduced, which is expected to improve the prognosis to the level of the population.

Keywords: hyperphosphatemia; hypocalcemia; Parathyroid hormone; pseudohypoparathyroidism

Received: February 21, 2021; Accepted: March 9, 2021; Published: June 11, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pseudohypoparathyroidism type Ib: a case report and review of literature. Clinical Osteology. 2021;26(1):40-44.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Underbjerg L, Sikjaer T, Mosekilde L et al. Pseudohypoparathyroidism -⁠ epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf) 2016; 84(6): 904-911. Dostupné z DOI: <http://dx.doi.org/10.1111/cen.12948>. Go to original source...
    2. Germain-Lee EL. Management of pseudohypoparathyroidism. Curr Opin Pediatr 2019; 31(4): 537-549. Dostupné z DOI: <http://dx.doi.org/10.1097/MOP.0000000000000783>. Go to original source...
    3. Nakamura Y, Matsumoto T, Tamakoshi A at al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 2000; 10(1): 29-33. Dostupné z DOI: <http://dx.doi.org/10.2188/jea.10.29>. Go to original source...
    4. Mantovani G, Bastepe M, Monk D et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol 2018; 14(8): 476-500. Dostupné z DOI: <http://dx.doi.org/10.1038/s41574-018-0042-0>. Go to original source...
    5. Lemos MC, Thakker RV. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders. Hum Mutat 2015; 36(1): 11-19. Dostupné z DOI: <http://dx.doi.org/10.1002/humu.22696>. Go to original source...
    6. Eyre WG, Reed WB. Albright hereditary osteodystrophy with cutaneous bone formation. Arch Dermatol 1971; 104(6): 634-642. Go to original source...
    7. Farfel Z, Friedman E. Mentaldeficiency in pseudohypoparathyroidism type I isassociated with Ns-proteindeficiency. Ann Intern Med 1986; 105(2): 197-199. Dostupné z DOI: <http://dx.doi.org/10.7326/0003-4819-105-2-197>. Go to original source...
    8. Mallette LE, Kirkland JL, Gagel RF et al. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. J Clin Endocrinol Metab 1988; 67(5): 964-972. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem-67-5-964>. Go to original source...
    9. Mantovani G, Spada A, Elli FM. Pseudohypoparathyroidism and Gsalpha-cAMP-linked disorders: current view and open issues. Nat Rev Endocrinol 2016; 12(6): 347-356. Dostupné z DOI: <http://dx.doi.org/10.1038/nrendo.2016.52>. Go to original source...
    10. Linglart A, Menguy C, Couvineau A et al. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 2011; 364(23): 2218-2226. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1012717>. Go to original source...
    11. Bringhurst FR, Demay BM, Kronenberg HM. Hormones and Disorders of Mineral Metabolism. In: Shlomo M (ed). Williams Textbook of Endocrinology. 14th ed. ELSEVIER: Philadelphia 2019 : 1242. ISBN 978-0323555968.
    12. Levine MA. An update on theclinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes 2012; 19(6): 443-451. Dostupné z DOI: <http://dx.doi.org/10.1097/MED.0b013e32835a255c>. Go to original source...
    13. Tafaj O, Juppner H. Pseudohypoparathyroidism: one gene, several syndromes. J Endocrinol Invest 2017; 40(4): 347-356. Dostupné z DOI: <http://dx.doi.org/10.1007/s40618-016-0588-4>. Go to original source...
    14. Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J ClinEndocrinolMetab 2011; 96(10): 3020-3030. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011-1048>. Go to original source...
    15. Fernandez-Rebollo E, Perez de Nanclares G, Lecumberri B et al. Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res 2011; 26(8): 1854-1863. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.408>. Go to original source...
    16. Štrbák V. Fyziológia endokrinného systemu. In: Javorka K (ed). Lekárska fyziológia. 3. prepracované a doplnené vyd. Osveta: Martin 2009 : 430-431. ISBN 9788080632915.
    17. Murray TM, Rao LG, Wong MM et al. Pseudohypoparathyroidism with osteitis fibrosacystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cutured from bone. J Bone Miner Res 1993; 8(1): 83-91. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.5650080111>. Go to original source...
    18. Chu X, Zhu Y, Wang O et al. Bone mineral density and its serial changes are associated with PTH levels in pseudohypoparathyroidism type 1B patients. J Bone Miner Res 2018; 33(4): 743-752. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.3360>. Go to original source...
    19. Neary NM, El-Maouche D, Hopkins R et al. Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab 2012; 97(9): 3025-3030. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2012-1655>. Go to original source...
    20. Park HS, Kim CG, Hong N et al. Osteosarcoma in a patient with pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q. J Bone Miner Res 2017; 32(4): 770-775. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.3043. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.